高N-糖基化SAMD14与neurabin-I作为原发性中枢神经系统淋巴瘤的驱动自身抗原
研究旨在探讨慢性抗原刺激在原发性中枢神经系统淋巴瘤(PCNSL)中的作用,发现12例PCNSL中8例的B细胞受体(BCR)自身抗原为SAMD14和neurabin-I,二者呈异常高N-糖基化(SAMD14在ASN339、neurabin-I在ASN1277),可诱导BCR通路激活和淋巴瘤细胞增殖,支持翻译后修饰的中枢神经系统驱动自身抗原在PCNSL发病中的作用。
要点
- 12例PCNSL中8例的BCR自身抗原为SAMD14和neurabin-I。
- SAMD14和neurabin-I在相应病例中呈异常高N-糖基化,解释其自身免疫原性。
- SAMD14和neurabin-I可诱导转染相应BCR的侵袭性淋巴瘤细胞系BCR通路激活和增殖。
核心结论
- 结果支持翻译后修饰的中枢神经系统驱动自身抗原通过慢性抗原刺激在PCNSL发病中起作用,并为其中枢神经系统趋向性提供解释及新型特异性治疗思路的基础。
研究设计与样本
- 研究为实验室基础研究,搜索自身抗原并鉴定12例PCNSL中8例的BCR自身抗原靶点。
主要发现
- 12例PCNSL中8例的BCR自身抗原靶点为SAMD14和neurabin-I。
- 在相应病例中,SAMD14和neurabin-I呈异常高N-糖基化(SAMD14在ASN339、neurabin-I在ASN1277)。
- SAMD14和neurabin-I可诱导转染SAMD14和neurabin-I反应性BCR的侵袭性淋巴瘤细胞系BCR通路激活和增殖。
- neurabin-I的BCR结合表位与截短型假单胞菌外毒素偶联物可杀死表达相应BCR的淋巴瘤细胞。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To address the role of chronic antigenic stimulation in primary central nervous system lymphoma (PCNSL), we searched for autoantigens and identified sterile α-motif domain containing protein 14 (SAMD14) and neural tissue-specific F-actin binding protein I (neurabin-I) as autoantigenic targets of the B-cell receptors (BCRs) from 8/12 PCNSLs. In the respective cases, SAMD14 and neurabin-I were atypically hyper-N-glycosylated (SAMD14 at ASN339 and neurabin-I at ASN1277), explaining their autoimmunogenicity. SAMD14 and neurabin-I induced BCR pathway activation and proliferation of aggressive lymphoma cell lines transfected with SAMD14- and neurabin-I-reactive BCRs. Moreover, the BCR binding epitope of neurabin-I conjugated to truncated Pseudomonas exotoxin-killed lymphoma cells expressing the respective BCRs. These results support the role of chronic antigenic stimulation by posttranslationally modified central nervous system (CNS) driver autoantigens in the pathogenesis of PCNSL, serve as an explanation for their CNS tropism, and provide the basis for a novel specific treatment approach.
引用
- Thurner L, Preuss KD, Bewarder M, et al. Hyper-N-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma. Blood. 2018. PMID: 30249786. doi:10.1182/blood-2018-03-836932
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。